Skip to main content
Erschienen in: Aesthetic Plastic Surgery 4/2018

14.05.2018 | Original Article

Comparative Study of UMA Jeunesse Classic® and UMA Jeunesse Ultra®

verfasst von: Peeyush P. Sharma, Dave Krishan Sharma, Andrew Carr

Erschienen in: Aesthetic Plastic Surgery | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Introduction

The emergence of hyaluronic acid dermal fillers with lidocaine has transformed the minimally invasive treatment of wrinkles, lines and folds of the face. Patients can be treated quickly, painlessly and without the need for large doses of lidocaine. Therefore, it is important to scientifically evaluate the merits of lidocaine-containing products over those without.

Methods

The two products, with (UJU) and without lidocaine (UJ), were randomly injected into nasolabial folds of 75 healthy volunteers with varying skin types in a split face study, age ranging 26–60 years. Only 73 subjects completed the follow-up. There were 68 females and 5 males with medium-to-deep nasolabial folds. All subjects were randomly injected with the two products on one or the other side of the face. Patients were followed up for 9 months.

Results

Both products achieved significant improvement in the wrinkle severity score. Overall results were slightly better with UJU due to ease of injection, lack of pain and avoidance of topical or parenteral anaesthetic. In all other respects, differences in clinical data were not statistically significant. UJU® was preferred by patients and injectors due to less pain during and after injection as compared to UJ® (P < 0.0001). The overall rate of early and late complications with the two products was similar. Duration of maintenance of aesthetic effect between products also showed similarity. Optimum aesthetic effect was maintained in most cases for over 9 months with both products but patients in the 30–50-year age group did better. The patient acceptability rate was much higher with UJU.

Conclusion

Clinical data from this study suggest that performance and outcomes of treatment of medium-to-deep nasolabial folds with UJ and UJU are quite similar. However, treatment with UJU offers enhanced patient comfort and is preferred by patients and injectors.

Level of Evidence I

This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.​springer.​com/​00266.
Literatur
1.
Zurück zum Zitat Royo de la Torre J, Moreno-Moraga J, Isarría MJ, Muñoz E, Cruz I, Pérez G, Cornejo P (2013) The evaluation of hyaluronic acid, with and without lidocaine, in the filling of nasolabial folds as measured by ultrastructural changes and pain management. J Drugs Dermatol 12(3):e46–52PubMed Royo de la Torre J, Moreno-Moraga J, Isarría MJ, Muñoz E, Cruz I, Pérez G, Cornejo P (2013) The evaluation of hyaluronic acid, with and without lidocaine, in the filling of nasolabial folds as measured by ultrastructural changes and pain management. J Drugs Dermatol 12(3):e46–52PubMed
2.
Zurück zum Zitat Prager W, Steinkraus V (2010) A prospective, rater-blind, randomized comparison of the effectiveness and tolerability of Belotero ® Basic versus Restylane ® for correction of nasolabial folds. Eur J Dermatol 20(6):748–752PubMed Prager W, Steinkraus V (2010) A prospective, rater-blind, randomized comparison of the effectiveness and tolerability of Belotero ® Basic versus Restylane ® for correction of nasolabial folds. Eur J Dermatol 20(6):748–752PubMed
3.
Zurück zum Zitat da Costa A, Biccigo DGZ, de Souza Weimann ET, Mercadante LM, Oliveira PRG, Prebianchi SB, Abdalla BMZ (2017) Durability of three different types of hyaluronic acid fillers in skin: are there differences among biphasic, monophasic monodensified, and monophasic polydensified products? Aesthet Surg J 37(5):573–581. https://doi.org/10.1093/asj/sjw161 PubMedCrossRef da Costa A, Biccigo DGZ, de Souza Weimann ET, Mercadante LM, Oliveira PRG, Prebianchi SB, Abdalla BMZ (2017) Durability of three different types of hyaluronic acid fillers in skin: are there differences among biphasic, monophasic monodensified, and monophasic polydensified products? Aesthet Surg J 37(5):573–581. https://​doi.​org/​10.​1093/​asj/​sjw161 PubMedCrossRef
4.
Zurück zum Zitat World Health Organization (2001) World medical association declaration of Helsinki. Ethical principles for medical research involving human subjects. Bull World Health Organ 79(4):373–374 World Health Organization (2001) World medical association declaration of Helsinki. Ethical principles for medical research involving human subjects. Bull World Health Organ 79(4):373–374
5.
Zurück zum Zitat Vijayananthan A, Nawawi O (2008) The importance of Good Clinical Practice guidelines and its role in clinical trials. Biomed Imaging Interv J 4(1):e5CrossRefPubMedPubMedCentral Vijayananthan A, Nawawi O (2008) The importance of Good Clinical Practice guidelines and its role in clinical trials. Biomed Imaging Interv J 4(1):e5CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Day DJ, Littler CM, Swift RW, Gottlieb S (2004) The wrinkle severity rating scale: a validation study. Am J Clin Dermatol 5:49–52CrossRefPubMed Day DJ, Littler CM, Swift RW, Gottlieb S (2004) The wrinkle severity rating scale: a validation study. Am J Clin Dermatol 5:49–52CrossRefPubMed
7.
Zurück zum Zitat Carruthers A, Carruthers J (2010) A validated facial grading scale: the future of facial ageing measurement tools? J Cosmet Laser Ther 12:235–241CrossRefPubMed Carruthers A, Carruthers J (2010) A validated facial grading scale: the future of facial ageing measurement tools? J Cosmet Laser Ther 12:235–241CrossRefPubMed
8.
Zurück zum Zitat Sharma P, Sharma S (2011) Comparative study of a new dermal filler Uma Jeunesse® and Juvéderm®. J Cosmet Dermatol 10(2):118–125CrossRefPubMed Sharma P, Sharma S (2011) Comparative study of a new dermal filler Uma Jeunesse® and Juvéderm®. J Cosmet Dermatol 10(2):118–125CrossRefPubMed
9.
Zurück zum Zitat Levy PM, De Boulle K, Raspaldo H (2009) A split-face comparison of a new hyaluronic acid facial filler containing pre-incorporated lidocaine versus a standard hyaluronic acid facial filler in the treatment of naso-labial folds. J Cosmet Laser Ther 11:169–173CrossRefPubMed Levy PM, De Boulle K, Raspaldo H (2009) A split-face comparison of a new hyaluronic acid facial filler containing pre-incorporated lidocaine versus a standard hyaluronic acid facial filler in the treatment of naso-labial folds. J Cosmet Laser Ther 11:169–173CrossRefPubMed
10.
Zurück zum Zitat Weinkle SH, Bank DE, Boyd CM et al (2009) A multi-center, double-blind, randomized controlled study of the safety and effectiveness of Juve´derm injectable gel with and without lidocaine. J Cosmet Dermatol 8(3):205–210CrossRefPubMed Weinkle SH, Bank DE, Boyd CM et al (2009) A multi-center, double-blind, randomized controlled study of the safety and effectiveness of Juve´derm injectable gel with and without lidocaine. J Cosmet Dermatol 8(3):205–210CrossRefPubMed
11.
Zurück zum Zitat Alam M, Dover JS (2007) Management of complications and sequelae with temporary injectable fillers. Plast Reconstr Surg 120(6 Suppl):98S–105SCrossRefPubMed Alam M, Dover JS (2007) Management of complications and sequelae with temporary injectable fillers. Plast Reconstr Surg 120(6 Suppl):98S–105SCrossRefPubMed
12.
Zurück zum Zitat Pinsky MA, Thomas JA, Murphy DK, Walker PS (2008) Juvederm injectable gel: a multicenter, double-blind, randomized study of safety and effectiveness. Aesthet Surg J 28(5):596–597CrossRef Pinsky MA, Thomas JA, Murphy DK, Walker PS (2008) Juvederm injectable gel: a multicenter, double-blind, randomized study of safety and effectiveness. Aesthet Surg J 28(5):596–597CrossRef
13.
Zurück zum Zitat Vedamurthy M (2008) IADVL Dermatosurgery task Force. Standard guidelines for the use of dermal fillers. Indian J Dermatol Venereol Leprol 74:S23–S27CrossRefPubMed Vedamurthy M (2008) IADVL Dermatosurgery task Force. Standard guidelines for the use of dermal fillers. Indian J Dermatol Venereol Leprol 74:S23–S27CrossRefPubMed
14.
Zurück zum Zitat Duranti F, Salti G, Bovani B, Calandra M, Rosati ML (1998) Injectable hyaluronic acid gel for soft tissue augmentation. A clinical and histological study. Dermatol Surg 24:1317–1325PubMed Duranti F, Salti G, Bovani B, Calandra M, Rosati ML (1998) Injectable hyaluronic acid gel for soft tissue augmentation. A clinical and histological study. Dermatol Surg 24:1317–1325PubMed
15.
Zurück zum Zitat Funt David, Pavicic Tatjana (2013) Dermal fillers in aesthetics: an overview of adverse events and treatment approaches. Clin Cosmet Investig Dermatol 6:295–316PubMedPubMedCentral Funt David, Pavicic Tatjana (2013) Dermal fillers in aesthetics: an overview of adverse events and treatment approaches. Clin Cosmet Investig Dermatol 6:295–316PubMedPubMedCentral
16.
Zurück zum Zitat Christensen LH (2009) Host tissue interaction, fate, and risks of degradable and nondegradable gel fillers. Dermatol Surg 35(Suppl 2):1612–1619CrossRefPubMed Christensen LH (2009) Host tissue interaction, fate, and risks of degradable and nondegradable gel fillers. Dermatol Surg 35(Suppl 2):1612–1619CrossRefPubMed
17.
Zurück zum Zitat Monheit GD, Rohrich RJ (2009) The nature of long-term fillers and the risk of complications. Dermatol Surg 35(Suppl 2):1598–1604CrossRefPubMed Monheit GD, Rohrich RJ (2009) The nature of long-term fillers and the risk of complications. Dermatol Surg 35(Suppl 2):1598–1604CrossRefPubMed
18.
Zurück zum Zitat Arsiwala SZ (2010) Safety and persistence of non-animal stabilized hyaluronic acid fillers for nasolabial folds correction in 30 indian patients. J Cutan Aesthet Surg 3(3):156–161CrossRefPubMedPubMedCentral Arsiwala SZ (2010) Safety and persistence of non-animal stabilized hyaluronic acid fillers for nasolabial folds correction in 30 indian patients. J Cutan Aesthet Surg 3(3):156–161CrossRefPubMedPubMedCentral
Metadaten
Titel
Comparative Study of UMA Jeunesse Classic® and UMA Jeunesse Ultra®
verfasst von
Peeyush P. Sharma
Dave Krishan Sharma
Andrew Carr
Publikationsdatum
14.05.2018
Verlag
Springer US
Erschienen in
Aesthetic Plastic Surgery / Ausgabe 4/2018
Print ISSN: 0364-216X
Elektronische ISSN: 1432-5241
DOI
https://doi.org/10.1007/s00266-018-1144-8

Weitere Artikel der Ausgabe 4/2018

Aesthetic Plastic Surgery 4/2018 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.